Related Experiment Videos
Adenylosuccinase deficiency: possibly underdiagnosed encephalopathy with variable clinical features
M Köhler1, B Assmann, C Bräutigam
1University Children's Hospital, Marburg, Germany.
Summary
Adenylosuccinase deficiency, a purine synthesis disorder, causes neurodevelopmental issues. Researchers identified two German cases, one with novel symptoms and a unique gene deletion, suggesting it
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Adenylosuccinase deficiency is an inherited metabolic disorder affecting purine synthesis.
- It leads to the accumulation of specific metabolites in bodily fluids.
- This condition is associated with neurodevelopmental abnormalities.
Observation:
- Two German patients with unidentified neurodegenerative disorders were diagnosed with adenylosuccinase deficiency.
- One patient presented with a previously undescribed severe early infantile epileptic encephalopathy and reduced myelination.
- This patient exhibited a novel 39 base pair deletion in the adenylosuccinase gene.
Findings:
- The study identified the first German cases of adenylosuccinase deficiency.
- Clinical manifestations include moderate to severe mental retardation, epilepsy, autistic features, growth retardation, and hypotonia.
- A novel genetic mutation (39 bp deletion) was identified in one patient, distinct from previously reported point mutations.
Implications:
- Adenylosuccinase deficiency may be underdiagnosed due to its variable clinical expression.
- The findings highlight the importance of considering this metabolic disorder in patients with unexplained neurological conditions.
- Genetic analysis, including detection of deletions, is crucial for accurate diagnosis.